Literature DB >> 17118787

The T-cell antigen receptor: a logical response to an unknown ligand.

Ed Palmer1.   

Abstract

The immune system can be roughly divided into innate and adaptive compartments. The adaptive compartment includes the B and T lymphocytes, whose antigen receptors are generated by recombination of gene segments. The consequence is that the creation of self-reactive lymphocytes is unavoidable. For the host to remain viable, the immune system has evolved a strategy for removing autoimmune lymphocytes during development. This review discusses how T lymphocytes are generated, how they recognize antigens, and how their antigen receptor directs the removal of self-reactive T cells.

Mesh:

Substances:

Year:  2006        PMID: 17118787     DOI: 10.1080/10799890600919094

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  5 in total

Review 1.  Epigenetic drug discovery: breaking through the immune barrier.

Authors:  David F Tough; Paul P Tak; Alexander Tarakhovsky; Rab K Prinjha
Journal:  Nat Rev Drug Discov       Date:  2016-10-21       Impact factor: 84.694

Review 2.  Tregs and rethinking cancer immunotherapy.

Authors:  Tyler J Curiel
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

3.  Age-related accumulation of T cells with markers of relatively stronger autoreactivity leads to functional erosion of T cells.

Authors:  Zohreh Tatari-Calderone; Milica Stojakovic; Ramita Dewan; Gama Le Bouder; Dragana Jankovic; Stanislav Vukmanovic
Journal:  BMC Immunol       Date:  2012-02-09       Impact factor: 3.615

4.  Distributed classifier based on genetically engineered bacterial cell cultures.

Authors:  Andriy Didovyk; Oleg I Kanakov; Mikhail V Ivanchenko; Jeff Hasty; Ramón Huerta; Lev Tsimring
Journal:  ACS Synth Biol       Date:  2014-11-11       Impact factor: 5.110

5.  A stochastic T cell response criterion.

Authors:  James Currie; Mario Castro; Grant Lythe; Ed Palmer; Carmen Molina-París
Journal:  J R Soc Interface       Date:  2012-06-28       Impact factor: 4.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.